Literature DB >> 2820641

Multiple myeloma: ecto-5' nucleotidase deficiency of suppressor/cytotoxic (CD8) lymphocytes is a marker for the expansion of suppressor T cells.

M Massaia1, U Dianzani, P Pioppo, E Sibilla, M Boccadoro, A Pileri.   

Abstract

In this study, 5'NT activity was investigated by radiochemical and cytochemical assays in T cell subpopulations of patients with multiple myeloma (MM). Cytotoxic/suppressor (CD8) and helper/inducer (CD4) lymphocytes were separated from peripheral blood by the panning technique, or sorted with a fluorescein activated cell sorter. 5'NT activity was significantly decreased in MM CD8 lymphocytes compared with the controls. By contrast, it was comparably low in CD4 subpopulations of normal controls and MM patients. The cytochemical assay indicated that a decreased number of 5'NT+ cells rather than a decreased activity per cell was responsible for 5'NT deficiency in MM CD8 lymphocytes. CD8 lymphocytes with the suppressor phenotype (OKMI+, granular cells) were significantly increased in MM. These data provide a phenotypic explanation for the enhanced suppressor activity displayed by T lymphocytes in MM. A significant correlation was found between the increase of suppressor cells and the decrease of 5'NT+ cells. 5'NT deficiency of CD8 lymphocytes can be a biochemical marker for the expansion of suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820641      PMCID: PMC1542394     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  Distribution of 5'-nucleotidase in human lymphoid tissues.

Authors:  N L Edwards; E W Gelfand; L Burk; H M Dosch; I H Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

3.  Enhanced T cell suppression is directed toward sensitive circulating B cells in multiple myeloma.

Authors:  R T Perri; M M Oken; N E Kay
Journal:  J Lab Clin Med       Date:  1982-04

4.  Enzymes of purine metabolism in human peripheral lymphocyte subpopulations.

Authors:  M Massaia; D D Ma; T A Sylwestrowicz; N Tidman; G Price; G Janossy; A V Hoffbrand
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

5.  5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia.

Authors:  T A Sylwestrowicz; D D Ma; P P Murphy; M Massaia; H G Prentice; A V Hoffbrand; M F Greaves
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

6.  Multiple myeloma: an immunologic profile. Cytotoxic and suppressive effects of the EA rosette-forming cell.

Authors:  T Paglieroni; M R Mackenzie
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

7.  Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma.

Authors:  R G Hoover; S Hickman; H M Gebel; N Rebbe; R G Lynch
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

8.  Human lymphocytes: 5'-nucleotidase-positive and -negative subpopulations.

Authors:  R Silber; M Conklyn; G Grusky; D Zucker-Franklin
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

9.  Ecto-5'-nucleotidase activity in human T cell subsets. Decreased numbers of ecto-5'-nucleotidase positive cells from both OKT4+ and OKT8+ cells in patients with hypogammaglobulinemia.

Authors:  L F Thompson; A Saxon; R D O'Connor; R I Fox
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

10.  Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage.

Authors:  K H Mills; J C Cawley
Journal:  Br J Haematol       Date:  1983-02       Impact factor: 6.998

View more
  3 in total

1.  Defective interleukin-2 induction of lymphokine-activated killer (LAK) activity in peripheral blood T lymphocytes of patients with monoclonal gammopathies.

Authors:  M Massaia; A Bianchi; U Dianzani; A Camponi; C Attisano; M Boccadoro; A Pileri
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

2.  Defective generation of alloreactive cytotoxic T lymphocytes (CTL) in human monoclonal gammopathies.

Authors:  M Massaia; U Dianzani; A Bianchi; A Camponi; M Boccadoro; A Pileri
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

3.  Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16.

Authors:  R G Hoover; C Lary; R Page; P Travis; R Owens; J Flick; J Kornbluth; B Barlogie
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.